NO980531D0 - Medikament for hemming av avhengighets og toleranse utviklet som fölge av et narkotisk smertestillende middel - Google Patents
Medikament for hemming av avhengighets og toleranse utviklet som fölge av et narkotisk smertestillende middelInfo
- Publication number
- NO980531D0 NO980531D0 NO980531A NO980531A NO980531D0 NO 980531 D0 NO980531 D0 NO 980531D0 NO 980531 A NO980531 A NO 980531A NO 980531 A NO980531 A NO 980531A NO 980531 D0 NO980531 D0 NO 980531D0
- Authority
- NO
- Norway
- Prior art keywords
- addiction
- drugs
- inhibition
- result
- narcotic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/402—1-aryl substituted, e.g. piretanide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20076395 | 1995-08-07 | ||
| PCT/JP1996/002207 WO1997006139A1 (fr) | 1995-08-07 | 1996-08-06 | Inhibiteur de la dependance / de la resistance a l'egard des analgesiques narcotiques |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO980531D0 true NO980531D0 (no) | 1998-02-06 |
| NO980531L NO980531L (no) | 1998-04-06 |
| NO315078B1 NO315078B1 (no) | 2003-07-07 |
Family
ID=16429771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19980531A NO315078B1 (no) | 1995-08-07 | 1998-02-06 | Anvendelse av en kjemisk forbindelse for fremstilling av et medikament forå hemme avhengighet og toleranse utviklet ved narkotisksmertestillende middel |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6107330A (no) |
| EP (1) | EP0844241B1 (no) |
| KR (1) | KR19990036248A (no) |
| CN (1) | CN1085979C (no) |
| AT (1) | ATE231491T1 (no) |
| AU (1) | AU6631396A (no) |
| CA (1) | CA2228813A1 (no) |
| DE (1) | DE69625913T2 (no) |
| DK (1) | DK0844241T3 (no) |
| ES (1) | ES2191763T3 (no) |
| NO (1) | NO315078B1 (no) |
| TW (1) | TW457087B (no) |
| WO (1) | WO1997006139A1 (no) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20000048847A (ko) * | 1996-10-01 | 2000-07-25 | 스즈키 다다시 | 미토콘드리아 막 안정화제 |
| WO1999003466A1 (fr) * | 1997-07-15 | 1999-01-28 | Daiichi Pharmaceutical Co., Ltd. | Substance prophylactique ou therapeutique contre l'amnesie |
| US6890951B2 (en) | 1998-08-05 | 2005-05-10 | Brookhaven Science Associates Llc | Treatment of addiction and addiction-related behavior |
| US20040077709A1 (en) * | 1999-05-31 | 2004-04-22 | Daiichi Pharmaceutical Co., Ltd. | Neuronal death inhibitors |
| US6423739B1 (en) | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
| US6348489B1 (en) | 2000-04-11 | 2002-02-19 | Daiichi Pharmaceutical Co., Ltd. | Method of treating traumatic brain injury and other neuronal disorders |
| KR100823668B1 (ko) * | 2000-12-28 | 2008-04-21 | 해밀턴 파마슈티컬스 인코포레이티드 | 신경성 통증 치료 및 예방약 |
| JP4505410B2 (ja) | 2002-10-29 | 2010-07-21 | サングキュンクワン ユニヴァースィティ | モルヒネへの心理的依存又は耐性を防止及び処置するのに有効成分としてベルベリンを含有する医薬組成物 |
| US20060241144A1 (en) * | 2005-04-20 | 2006-10-26 | Albert Cha | Method for treating apathy syndrome |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5198317A (en) * | 1975-02-21 | 1976-08-30 | 22 okisopirorijin 11 iruasetamidochushaekinoseizoho | |
| US4212878A (en) * | 1978-01-26 | 1980-07-15 | The Upjohn Company | Phenylacetamide derivative analgesics |
| IT1141287B (it) * | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono |
| US4490167A (en) * | 1979-08-06 | 1984-12-25 | Ciba-Geigy Corporation | Oxime derivatives of diphenyl ethers and their use in herbicidal compositions |
| BE893276A (fr) * | 1981-06-01 | 1982-11-24 | Sandoz Sa | Nouvelle application therapeutique d'un derive de l'acetamide |
| US5468749A (en) * | 1988-08-30 | 1995-11-21 | Gawin; Frank H. | Method for treatment of substance addiction |
| US5185329A (en) * | 1988-08-30 | 1993-02-09 | Bristol-Myers Squibb Company | Method for treatment of substance addiction |
| IL91451A0 (en) * | 1988-08-30 | 1990-04-29 | Bristol Myers Co | Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction |
| DE415693T1 (de) * | 1989-08-28 | 1991-10-17 | Arizona Technology Development Corp., Tucson, Ariz., Us | Zusammensetzung und verfahren zur selektiven verstaerkung der opiat-wirkung und verminderung von opiat-toleranz und abhaengigkeit. |
| IL101514A (en) * | 1991-04-10 | 1996-01-31 | Merck & Co Inc | History of benzodiazepines and anticoagulants containing cholecystokinin containing them |
| US5220018A (en) * | 1991-04-10 | 1993-06-15 | Merck & Co., Inc. | Cholecystokinin antagonists |
| JPH0517421A (ja) * | 1991-07-10 | 1993-01-26 | Yamanouchi Pharmaceut Co Ltd | Ｎ−置換アミド誘導体 |
| FI102748B1 (fi) * | 1992-06-19 | 1999-02-15 | Daiichi Seiyaku Co | Menetelmä N-(2,6-dialkyylifenyyli)-2-(2-okso-1-pyrrolidinyyli)asetamidijohdannaisen valmistamiseksi |
| US5461157A (en) * | 1992-06-19 | 1995-10-24 | Daiichi Pharmaceutical Co., Ltd. | Process for preparing pyrrolidinylacetamide derivatives |
-
1995
- 1995-08-06 US US09/000,236 patent/US6107330A/en not_active Expired - Fee Related
-
1996
- 1996-08-06 TW TW085109475A patent/TW457087B/zh not_active IP Right Cessation
- 1996-08-06 KR KR1019980700916A patent/KR19990036248A/ko active IP Right Grant
- 1996-08-06 CN CN96197355A patent/CN1085979C/zh not_active Expired - Fee Related
- 1996-08-06 EP EP96926004A patent/EP0844241B1/en not_active Expired - Lifetime
- 1996-08-06 DE DE69625913T patent/DE69625913T2/de not_active Expired - Fee Related
- 1996-08-06 DK DK96926004T patent/DK0844241T3/da active
- 1996-08-06 AT AT96926004T patent/ATE231491T1/de not_active IP Right Cessation
- 1996-08-06 AU AU66313/96A patent/AU6631396A/en not_active Abandoned
- 1996-08-06 WO PCT/JP1996/002207 patent/WO1997006139A1/ja active IP Right Grant
- 1996-08-06 CA CA002228813A patent/CA2228813A1/en not_active Abandoned
- 1996-08-06 ES ES96926004T patent/ES2191763T3/es not_active Expired - Lifetime
-
1998
- 1998-02-06 NO NO19980531A patent/NO315078B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1198738A (zh) | 1998-11-11 |
| DE69625913D1 (de) | 2003-02-27 |
| EP0844241A1 (en) | 1998-05-27 |
| DK0844241T3 (da) | 2003-05-12 |
| ATE231491T1 (de) | 2003-02-15 |
| EP0844241B1 (en) | 2003-01-22 |
| CA2228813A1 (en) | 1997-02-20 |
| ES2191763T3 (es) | 2003-09-16 |
| US6107330A (en) | 2000-08-22 |
| NO980531L (no) | 1998-04-06 |
| CN1085979C (zh) | 2002-06-05 |
| DE69625913T2 (de) | 2003-11-27 |
| TW457087B (en) | 2001-10-01 |
| EP0844241A4 (en) | 1998-11-18 |
| NO315078B1 (no) | 2003-07-07 |
| AU6631396A (en) | 1997-03-05 |
| WO1997006139A1 (fr) | 1997-02-20 |
| KR19990036248A (ko) | 1999-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE122008000051I1 (de) | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel | |
| EP1312601A4 (en) | CARBOXYLENE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE | |
| EP0670309A4 (en) | RELATED TO PROLYE-ENDOPEPTIDASE INHIBITING ACTIVITY AND THEIR PHARMACEUTICAL USE. | |
| WO1999012532A3 (en) | Piperidine derivatives against malaria | |
| BR9201854A (pt) | Composto derivado de pridazinas,processo para sua preparacao,e,composicao farmaceutica | |
| NO975666D0 (no) | Pyrroldovater og medisinsk sammensetning | |
| DE69401584D1 (de) | Beta,beta-dimethyl-4-piperidinethanamin-derivate als inhibitoren der cholesterin-biosynthese | |
| KR950016731A (ko) | 지루 및 좌창의 억제 방법 | |
| EP1314719A4 (en) | BENZOIC ACID DERIVATIVES AND MEDICAMENTS HAVING THE SAME AS ACTIVE INGREDIENT | |
| NO980531D0 (no) | Medikament for hemming av avhengighets og toleranse utviklet som fölge av et narkotisk smertestillende middel | |
| BR9506552A (pt) | Método de inibição de integrase retroviral | |
| HUP0003039A2 (hu) | Szinergetikus fungicid hatóanyagkeverék és alkalmazása | |
| AR003137A1 (es) | Una composicion farmaceutica para tratar la leucemia | |
| YU44202A (sh) | Kvaternerne soli n-substituisanih cikiličnih ili ne- cikličnih amina kao farmaceutski preparati | |
| ATE245447T1 (de) | Inhibitor von gehirnödemen | |
| ZA9510908B (en) | Pharmaceutical compounds | |
| HUP0004900A2 (hu) | Mozgászavarok kezelésére szolgáló, hatóanyagként NMDA-receptor antagonista hatású piperidinszármazékokat tartalmazó gyógyszerkészítmények | |
| ATE172959T1 (de) | Acylphenylglycin-derivat und dieses als aktivbestandteil enthaltendes vorbeugungs -und heilmittel gegen durch erhöhte collagenaseaktivität verursachte krankheiten | |
| DK0863752T3 (da) | Anvendelse af alkylaminderivater såsom terbinafin ved fremstillingen af et lægemiddel til behandling af ledsagende sygdomme af en helicobacter pylori-infektion. | |
| DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| DE60026559D1 (de) | Arzneimittel gegen essstörungen | |
| AU1287892A (en) | Method of inhibiting the progressive development of diabetes mellitus | |
| NO964921D0 (no) | Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse | |
| TH19066A (th) | วิธีสำหรับยับยั้งการเพิ่มจำนวนเซลล์กล้ามเนื้อเรียบและภาวะการตีบของหลอดเลือด | |
| TH23898A (th) | วิธีการหยุดยั้งการออกฤทธิ์ของ il-6 |